141 related articles for article (PubMed ID: 7899283)
1. Gene therapy for cystic fibrosis: will it affect the uptake of prenatal carrier screening?
Mennie ME; Compton ME; Liston WA; Brock DJ
Prenat Diagn; 1994 Dec; 14(12):1158-62. PubMed ID: 7899283
[TBL] [Abstract][Full Text] [Related]
2. Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing.
Mennie ME; Gilfillan A; Compton ME; Liston WA; Brock DJ
Prenat Diagn; 1993 Sep; 13(9):807-14. PubMed ID: 8278311
[TBL] [Abstract][Full Text] [Related]
3. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).
Henneman L; Bramsen I; Van Os TA; Reuling IE; Heyerman HG; van der Laag J; van der Ploeg HM; ten Kate LP
Prenat Diagn; 2001 Jan; 21(1):1-9. PubMed ID: 11180232
[TBL] [Abstract][Full Text] [Related]
4. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
[TBL] [Abstract][Full Text] [Related]
5. Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.
Mennie ME; Liston WA; Brock DJ
J Med Genet; 1992 May; 29(5):308-12. PubMed ID: 1583657
[TBL] [Abstract][Full Text] [Related]
6. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
[TBL] [Abstract][Full Text] [Related]
7. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre.
Conway SP; Allenby K; Pond MN
Clin Genet; 1994 Jun; 45(6):308-12. PubMed ID: 7923862
[TBL] [Abstract][Full Text] [Related]
8. Effect of introducing prenatal diagnosis on the reproductive behaviour of families at risk for cystic fibrosis. A cohort study.
Borgo G; Fabiano T; Perobelli S; Mastella G
Prenat Diagn; 1992 Oct; 12(10):821-30. PubMed ID: 1475251
[TBL] [Abstract][Full Text] [Related]
9. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
Modra LJ; Massie RJ; Delatycki MB
Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for cystic fibrosis.
Mennie ME; Gilfillan A; Compton M; Curtis L; Liston WA; Pullen I; Whyte DA; Brock DJ
Lancet; 1992 Jul; 340(8813):214-6. PubMed ID: 1353143
[TBL] [Abstract][Full Text] [Related]
11. Active cascade testing for carriers of cystic fibrosis gene.
Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
Mennie ME; Axworthy D; Liston WA; Brock DJ
Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
[TBL] [Abstract][Full Text] [Related]
13. Association between carrier screening and incidence of cystic fibrosis.
Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
[TBL] [Abstract][Full Text] [Related]
14. Antenatal screening for cystic fibrosis: a trial of the couple model.
Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis: a look into the future of prenatal screening and therapy.
Nishida K; Smith Z; Rana D; Palmer J; Gallicano GI
Birth Defects Res C Embryo Today; 2015 Mar; 105(1):73-80. PubMed ID: 25820246
[TBL] [Abstract][Full Text] [Related]
16. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
[TBL] [Abstract][Full Text] [Related]
17. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
18. An update on cystic fibrosis screening.
Goetzinger KR; Cahill AG
Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
[TBL] [Abstract][Full Text] [Related]
19. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis.
Denayer L; Evers-Kiebooms G; De Boeck K; Van den Berghe H
Am J Med Genet; 1992 Sep; 44(1):104-11. PubMed ID: 1519639
[TBL] [Abstract][Full Text] [Related]
20. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
